Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $3.87 million. The enterprise value is -$2.12 million.
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024, before market open.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BDRX has 580,839 shares outstanding.
Shares Outstanding | 580,839 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 8.38% |
Float | 391,685 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.83 |
Forward PS | n/a |
PB Ratio | 0.21 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.04.
Current Ratio | 2.16 |
Quick Ratio | 2.16 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -96.81 |
Financial Efficiency
Return on equity (ROE) is -97.23% and return on invested capital (ROIC) is -55.03%.
Return on Equity (ROE) | -97.23% |
Return on Assets (ROA) | -37.52% |
Return on Capital (ROIC) | -55.03% |
Revenue Per Employee | $4,995 |
Profits Per Employee | -$410,371 |
Employee Count | 21 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | -307,101 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.04% in the last 52 weeks. The beta is 1.43, so BDRX's price volatility has been higher than the market average.
Beta (5Y) | 1.43 |
52-Week Price Change | -93.04% |
50-Day Moving Average | 8.89 |
200-Day Moving Average | 23.20 |
Relative Strength Index (RSI) | 47.40 |
Average Volume (20 Days) | 476,344 |
Short Selling Information
Short Interest | 27,649 |
Short Previous Month | 331,901 |
Short % of Shares Out | 4.76% |
Short % of Float | 7.06% |
Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, BDRX had revenue of $104,895 and -$8.62 million in losses. Loss per share was -$45.20.
Revenue | 104,895 |
Gross Profit | 183,250 |
Operating Income | -8.32M |
Pretax Income | -9.56M |
Net Income | -8.62M |
EBITDA | -8.14M |
EBIT | -8.32M |
Loss Per Share | -$45.20 |
Full Income Statement Balance Sheet
The company has $6.39 million in cash and $482,768 in debt, giving a net cash position of $5.91 million or $10.17 per share.
Cash & Cash Equivalents | 6.39M |
Total Debt | 482,768 |
Net Cash | 5.91M |
Net Cash Per Share | $10.17 |
Equity (Book Value) | 11.03M |
Book Value Per Share | 30.42 |
Working Capital | 5.11M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$9.80 million and capital expenditures -$27,803, giving a free cash flow of -$10.11 million.
Operating Cash Flow | -9.80M |
Capital Expenditures | -27,803 |
Free Cash Flow | -10.11M |
FCF Per Share | -$17.40 |
Full Cash Flow Statement Margins
Gross Margin | 174.70% |
Operating Margin | -7,931.30% |
Pretax Margin | -8,508.41% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -2,036.59% |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -227.91% |
FCF Yield | -267.25% |
Analyst Forecast
The average price target for BDRX is $200.00, which is 2,903.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $200.00 |
Price Target Difference | 2,903.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | -70.02% |
EPS Growth Forecast (5Y) | -85.75% |
Stock Forecasts Stock Splits
The last stock split was on October 4, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Oct 4, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
BDRX has an Altman Z-Score of -15.64 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.64 |
Piotroski F-Score | 1 |